James E. Wooldridge

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

George J. Weiner, Hsin-Ming Liu, James E. Wooldridge et al. · Proceedings of the National Academy of Sciences · 1997 · 522 citations

Life Sciences, Immunology, Oncology +17

Response Assessment of Aggressive Non-Hodgkin’s Lymphoma by Integrated International Workshop Criteria and Fluorine-18–Fluorodeoxyglucose Positron Emission Tomography

Malik E. Juweid, Gregory A. Wiseman, Julie M. Vose et al. · Journal of Clinical Oncology · 2005 · 387 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study

Bertrand Coiffier, Stéphane Leprêtre, Lars Møller Pedersen et al. · Blood · 2007 · 385 citations

Medicine, Hematology, Oncology +16

Improved Survival of Follicular Lymphoma Patients in the United States

Wade T. Swenson, James E. Wooldridge, Charles F. Lynch et al. · Journal of Clinical Oncology · 2005 · 263 citations

Medicine, Biostatistics, Oncology +16

Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab

J. A. Bowles, Siao‐Yi Wang, Brian K. Link et al. · Blood · 2006 · 224 citations · Full text

Life Sciences, Immunology, Oncology +17